INTRODUCTION
============

Cancers of immune system are classified into two major groups including Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). B-cell NHL lymphomas comprise a large group of lymphomas, such as, Burkitt lymphoma, diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, immunoblastic large cell lymphoma, precursor B-lymphoblastic lymphom, and mantle cell lymphoma. T-cell NHL lymphomas include mycosis fungoides, anaplastic large cell lymphoma and precursor T-lymphoblastic lymphoma ([@CIT0009]).

In the USA, NHL is the fifth prominent position of new cancer cases among men and women. In 2002, 2.8% of all cancers were NHL worldwide. NHLs are more common in the developed countries ([@CIT0009]). DLBCL, the most common subset of NHL, is clinically heterogeneous so that only 40% of patients respond to current treatments and have prolonged survival, while the remainders are submitted against the disease. Using microarray technology, systematic patterns of gene expression are examined in B-cell malignancies ([@CIT0001]). In order to study the behavior and function of cells, it is possible to investigate the expression levels of thousands of genes simultaneously using microarray technology ([@CIT0013]). Different levels of gene expression in DLBCL lead to differences in tumor proliferation rate, host response and the different situation of tumor ([@CIT0001]). Accordingly, the survival time of cancerous patients can be estimated based on gene expression profile ([@CIT0007]).

The discovery of the relationship between survival time and tumor expression profiles provided the possibility to achieve more accurate diagnosis and more advanced treatment ([@CIT0007]). In survival analysis, the time to reach an event may sometimes be censored. In this case, using the standard statistical methods is not possible. Many methods are introduced for such data ([@CIT0018]; [@CIT0019]). One of the most popular methods is Cox proportional hazard model. In the classic situation in which the number of sample *n* is larger than the number of variables *p* *(i.e., n\>p)*, the parameters of regression are estimated by maximizing Cox partial likelihood function, but in microarray data in which the number of sample *n* is smaller than the number of variables *p* (*n\<p*), using this method alone may not be appropriate ([@CIT0007]).

In recent years, both simple dimension reduction methods and more complex methods have been widely used to predict the survival of cancer patients based on gene expression data ([@CIT0007]; [@CIT0015]; [@CIT0014]). But few studies conducted to compare dimension reduction methods for this purpose ([@CIT0007]). The present study was conducted based on gene expression data using Cox regression in combination with seven dimension reduction methods in order to predict survival time in patients with DLBCL and to determine the influential genes on survival time.

MATERIALS AND METHODS
=====================

In this historical cohort, which was performed in 2010, we used DLBCL dataset including 4026 genes expression obtained based on array method of complementary DNA ([@CIT0001]). Data are available from: http://llmpp.nih.gov. The dataset contained survival time of 40 DLBCL patients. The desired event was death due to DLBCL disease and response variable was survival time of DLBCL patients after chemotherapy. Almost 45% of the survival time of patients was right censored.

The expression of gene was not specified for a large part of the dataset because of missing data. Since, the statistical methods used in this study could not be applied to missing data, these genes were deleted. After deleting this part of the dataset, the number of remaining genes reduced to 2042 genes.

To predict survival of patients with DLBCL based on gene expression, we combined Cox regression model (1) with seven dimension reduction methods ([@CIT0007]). A popular survival hazard function is introduced by Cox in the form:
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where, *X~i~ = X~1~, X~2~, ..., X~p~* represents predictive or explanatory variables (gene expression values), *h~0~(t)* represents basic or primary function of risk, and *h(t)* represents hazard rate or risk of death at time *t*.

Dimension reduction methods that used in this study were univariate selection ([@CIT0007]), forward stepwise selection ([@CIT0007]), principal component regression ([@CIT0007]), supervised principal component regression ([@CIT0004]; [@CIT0007]), partial least squares regression ([@CIT0007]; [@CIT0020]), ridge regression and the Lasso ([@CIT0007]).

The dimension reduction methods need the tuning parameter to determine the dimension reduction or shrinkage rate. The tuning parameter for univariate and forward stepwise selection methods is the number of genes, for two principal component methods and partial least squares regression is the number of linear combinations, and for ridge regression and Lasso is the shrinkage rate. In this study, the optimal tuning parameter (λ) was determined by cross-validation method ([@CIT0007]). Dimension reduction and prediction methods are summarized as follows:

In the univariate selection method, each gene expression value was tested alone on survival time using the univariate Cox regression model. Following testing each gene, they were sorted according to their *P* values. Then, λ first arranged genes that had the lowest *P* value were entered in multiple Cox regression model ([@CIT0007]).

In the forward stepwise selection method, at the first stage of the study, the most significant gene was selected using univariate Cox regression. In the second step, the selected gene and the other most significant gene was added to the Cox regression method. This approach continued until λ genes were selected ([@CIT0007]).

In principal component regression (PCR), the principal component of gene expressions was formed. Then, λ first principal components that had the greatest variance were entered in Cox regression model ([@CIT0007]).

In supervised principal component regression method (SPCR), at first, the λ~1~ percent of the ranked genes were selected according to their *P* value using univariate Cox regression. Then a principal component regression method was applied on this subset of genes. Finally, λ~2~ principal components were entered in the multiple Cox regression model. In this method, the tuning parameter was two-state (*λ=λ~1~,λ~2~*) ([@CIT0005]; [@CIT0004]; [@CIT0007]).

In partial least squares regression (PLS), PLS components were similar to the principal components except that the PLS used combinations that were correlated with survival time. There were many methods to perform PLS for Cox regression. We used the method which was proposed by Nygard et al ([@CIT0007]; [@CIT0020]).

In ridge regression, the regression coefficients were shrunk by imposing a penalty on the square value of the coefficients. For the Cox model, regression coefficients were estimated by maximizing the penalized log partial likelihood function:
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where *l(β)* is log partial likelihood function and,
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was the penalty term ([@CIT0007])

Also, lasso is a method for variable selection and shrinkage in Cox proportional hazard model. This method, similar to ridge regression, shrinks regression coefficients towards zero. The difference is that the penalty term is the absolute value of coefficients instead of squared values of the Cox regression coefficients ([@CIT0007]).

In order to evaluate the selected methods, dataset was split randomly into two parts, the training-set including a sample of 27 for estimation of the regression coefficients and the test-set including a sample of 13 for evaluating the performance of prediction model ([@CIT0007]). Data splitting was repeated 50 times randomly because if we used only one split of the data, it was not known to which extent the values of resulting criteria may depend on the actual training/test randomization ([@CIT0007]).

The estimation of parameters (![](JMGM-06-287-IM001.jpg)) for each dimension reduction method was obtained through the following two stages. First, the optimal tuning parameter value (![](JMGM-06-287-IM002.jpg)) was defined using the 10-fold cross-validation, then the specified ![](JMGM-06-287-IM001.jpg) was estimated using ![](JMGM-06-287-IM002.jpg). For each *ith* patient in the test set, prognostic index (PI) was estimated as follows ([@CIT0007]);
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where, *x~i~* was gene expression vector for *ith* patient in the test set.

The performance of a method was appropriate when the PI described the actual survival time of patients. There are different criteria to evaluate how well the survival times are described. The criteria which were examined in this study included log rank test, prognostic index test and deviance ([@CIT0007]).

In log rank test, patients in the test set were divided into two groups based on the median of ![](JMGM-06-287-IM003.jpg) the index. To evaluate the performance of this grouping, log rank test was applied. The *P* value was used as a basis for evaluation ([@CIT0007]).

Prognostic index is a criterion in which the ![](JMGM-06-287-IM003.jpg) index is used as a continuous covariate in a Cox regression model. The *P* value of the likelihood ratio test was considered as basis for evaluation ([@CIT0007]).

Also, deviance is a criterion in which the difference in deviance between the fitted model and the null model is computed as ![](JMGM-06-287-IM004.jpg) and 1^(test)^ (0)\] are the Cox log partial likelihood for the test data evaluated in ![](JMGM-06-287-IM001.jpg) and zero, respectively. Its *P* value is used as a basis for evaluation ([@CIT0007]).

In these criteria, the comparison of the fitted model was done with the null model in which all PIs were zero and was equivalent to the model with no gene expression for prediction. Three criteria were calculated for each of the seven dimension reduction methods in 50 training/test split of data and the median of each criteria was considered as basis for evaluation. The smaller values of the criterion expressed the better performance of prediction ([@CIT0007]).

In order to determine the influential genes on survival time for PCR, SPCR, PLS and ridge regression methods, different cut points were tried. Cut point is an index for keeping or removing predictive variable according to its Cox regression coefficient. For standardized variables, the coefficients close to zero express a little effect on the outcome. Therefore, the variable can be excluded from the model. Different values of cut point resulted in different number of variables. The cut point value is determined based on sample size. MATLAB r2008a and RKWard statistical programs were used for data analysis.

RESULTS
=======

The survival time of the patients ranges from 1.3 to 129.9 months. The median survival time, using Kaplan--Meir approach, was 32.5 months. [Figure 1](#F1){ref-type="fig"} shows the box plots of *P* values resulted from three performance criteria for seven prediction methods in 50 training/test split of data. Accordingly, ridge regression method shows the smallest median among the three criteria and thus has highest capability of prediction. The spread of box plot diagrams represents difference between the results of one split to another.

![Box plots of *p*-value resulting from three performance criteria for seven prediction methods. The horizontal lines represent the null model with no gene information included. The smaller the value of each criterion, the better the performance of prediction will be. **Uni**: Univariate selection, **FS**: Forward stepwise selection, **PCR**: Principal component regression, **SPCR**: Supervised PCR, **PLS**: Partial least square.](JMGM-06-287-g001){#F1}

Ridge regression is a shrinkage method. Sixteen genes had absolute values greater than the cut point of 0.06 ([Table 1](#T1){ref-type="table"}). Finally, four out of 16 genes were selected using forward stepwise selection in last step using Cox regression model (*P*\<0.05). [Table 2](#T2){ref-type="table"} shows the coefficients, hazard ratios and their 95% confidence intervals for these four genes. According to the estimated prognostic (PI) index and the three mentioned criteria, these four genes had the highest capability for prediction (*P*\<0.001). Based on calculated hazard ratio, four genes were diagnosed as influential factors on DLBCL survival. The expression of genes GENE3555X and GENE3807X decreased the survival time (*P*=0.008 and *P*=0.003, respectively), whereas the expression of genes GENE3228X and GENE1551X increased survival time (*P*=0.002 and *P*\<0.001, respectively).

###### 

Influential genes on DLBCL survival based on the cut point value of 0.06 using ridge regression model

  Gene code                                         Gene name
  ------------------------------------------------- -----------------------------------------------------------------------------------------------------
  **GENE3807X**[^a^](#tf1-1){ref-type="table-fn"}   OSE: (2'-5') oligoadenylate synthetase E; Clone=276483
  GENE2536X                                         BCL-2; Clone=342181
  GENE3831X                                         Lymphotoxin-Beta=Tumor necrosis factor C; Clone=712066
  **GENE3555X**[^a^](#tf1-1){ref-type="table-fn"}   LIgGFc: Low-affinity IgG Fc receptor II-B and C isoforms (multiple orthologous genes); Clone=292524
  GENE3554X                                         Low-affinity IgG Fc receptor II-B and C isoforms (multiple orthologous genes); Clone=1233864
  GENE2387X                                         Unknown UG Hs.181297 ESTs; Clone=1336563
  **GENE3228X**[^a^](#tf1-1){ref-type="table-fn"}   JNK3: Stress-activated protein kinase; Clone=23173
  GENE3317X                                         CD10=CALLA=Neprilysin=enkepalinase; Clone=701606
  GENE3318X                                         CD10=CALLA=Neprilysin=enkepalinase; Clone=1286850
  GENE3391X                                         CD21=B-lymphocyte CR2-receptor (for complement factor C3d and Epstein-Barr virus); Clone=824695
  GENE1190X                                         SLAM=signaling lymphocytic activation molecule; Clone=814251
  GENE1214X                                         Unknown UG Hs.89104 ESTs; Clone=713158
  GENE1161X                                         Unknown UG Hs.136858 EST; Clone=1317052
  GENE62X                                           p16-INK4a=Cyclin-dependent kinase 4 inhibitor A=Multiple tumor suppressor 1=MTS1; Clone=1174836
  GENE1819X                                         Unknown UG Hs.221250 ESTs; Clone=686150
  **GENE1551X**[^a^](#tf1-1){ref-type="table-fn"}   IL-2 receptor beta chain; Clone=1372713

Effective genes on DLBCL survival

###### 

Estimated parameters using Cox regression model

  Gene code   (*β~i~*)   SE[^a^](#tf2-1){ref-type="table-fn"}   Wald     df[^b^](#tf2-2){ref-type="table-fn"}   *P* value   Exp(*β~i~*)   95% CI for Exp(β~i~)   
  ----------- ---------- -------------------------------------- -------- -------------------------------------- ----------- ------------- ---------------------- -------
  GENE3807X   1.024      0.340                                  9.086    1                                      0.003       2.785         1.431                  5.421
  GENE3555X   0.671      0.255                                  6.932    1                                      0.008       1.957         1.187                  3.225
  GENE3228X   -1.298     0.418                                  9.623    1                                      0.002       0.273         0.120                  0.620
  GENE1551X   -1.299     0.326                                  15.881   1                                      0.000       0.273         0.144                  0.517

Standard error

Degree of freedom

DISCUSSION
==========

It was indicated that, based on three mentioned criteria, ridge regression had higher capability of prediction than other dimension reduction methods. Based on the pre-determined cut point for ridge regression coefficients and using forward stepwise selection of Cox survival model, four genes were diagnosed as influential genes on DLBCL survival. Accordingly, these genes can predict the survival time of the patients with DLBCL, if they are used simultaneously. The expression of genes GENE3555X and GENE3807X can decrease the survival time, whereas the genes GENE3228X and GENE1551X may increase survival time. Based on the previous biological studies, the expression of genes GENE3807X ([@CIT0010]; [@CIT0016]), GENE3228X ([@CIT0023]; [@CIT0024]), GENE3555X ([@CIT0012]) and GENE1551X ([@CIT0011]; [@CIT0008]) could affect the cancer cells and thus any disorder in expression these four genes could alter the prognosis of the patients.

Hastie et al performed a study on the same dataset using gene shaving method. Their method identified a small cluster of genes expression three of which were highly related to the survival including GENE3807X, GENE3555X and GENE3228X ([@CIT0012]). Sha et al proposed a Bayesian variable selection approach. They selected a set of four genes as being associated with DLBCL survival, one of which was GENE3228X ([@CIT0021]). Ando et al proposed kernel mixture modeling method and reported a set of 20 genes including GENE3555X which could be used for prediction of both cancer type and survival of cancer patient ([@CIT0002]).

An important limitation of the present study was that gene expression was not specified for a large part of the dataset. Deletion of this large part of dataset may prone the results of the present study to selection bias. In addition, we could not assess the effect of the reported genes on the pathogenesis or progress of DLBCL; hence, we suggest that the pathogenic effect of these genes being evaluated in the future studies. These genes were similar with those genes that we obtained in this study.

Lossos et al measured 36 genes concerning DLBCL survival in 66 patients using univariate Cox regression model. They entered six genes in Cox regression that had the score statistics greater than 1.5, and examined model validation using two other dataset. The genes were LMO2, BCL6, FN1, CCND2, SCYA3 and BCL2 ([@CIT0017]). These genes were dissimilar with those genes that we obtained in this study. A possible reason for this discrepancy is that the methods of gene selection were different. In addition, based on the three criteria used in this study, ridge regression method was much more powerful than the other methods such as univariate Cox regression model which was used by Lossos.

Shipp et al conducted a cohort study on 13 genes in 58 lymphoma patients. They reported that the two genes NR4A3 and PDE4B could affect the survival time ([@CIT0022]). Beer et al used DLBCL gene expression data in order to predict survival time using dimension reduction methods including principal component, supervised principal components and partial least square method. They reported that supervised principal component method had higher capability for prediction ([@CIT0004]), while, based on our findings, the prediction capability of principal component and supervised principal component methods was almost the same. However, Beer et al used only one training/test split of data to avoid random variability, while we used from 50 training/test split of data. Annest et al used DLBCL dataset to estimate survival in lymphoma patients employing iterative Bayesian Model Averaging (BMA) algorithm. They detected 25 influential genes using three selected models ([@CIT0003]).

Bovelstad et al applied seven reduction dimension methods in order to predict survival in patients with DLBCL using gene expression dataset. Their results indicated that the ridge regression had best performance totally ([@CIT0007]). Bovelstad et al used both clinical information and gene expression data in order to predict survival time using reduction dimension methods. They reported that clinic-genomic model had better performance than genomic or clinical data alone ([@CIT0006]). Therefore, a further study based on clinic-genomic model is suggested for factors affecting survival of patients with DLBCL.

Expression levels of influential genes on survival time play a role as either risk factors or preventive factors. Hence, determining the expression levels of such genes might be helpful for primary prevention programs. On the other hand, the expression levels of these genes could influence the survival time, therefore, they could be considered as prognostic factors in secondary prevention.

CONCLUSION
==========

This study indicated that ridge regression method has higher capability than other dimension reduction methods for prediction of survival time in patients with DLBCL. Furthermore, a combination of statistical methods and microarray data can help detecting influential genes in survival time.
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